Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, were quoted in this article. Read More
Share This Story
Hong-yu Li, PhD, professor, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, and Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, were quoted in this article. Read More
Share This Story
The ability of macrophages, a type of white blood cell, to transition into one of two forms, is critical for immune system functionality. These cells can morph into fighter cells (M1) that cause inflammation and attack invading pathogens, or nurse cells (M2) that soothe the inflammation and promote tissue repair after the battle. While researchers […]
Share This Story
Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]
Share This Story
Firefighting is classified as a known human carcinogen by the International Agency for Research on Cancer. Occupational cancer has become the leading cause of death among firefighters.
Share This Story
On April 5, more than a thousand participants gathered for the annual Give Cancer the Boot Survivorship 5K and 1-Mile Walk, dedicated to honoring survivors and supporting those still in treatment.
Share This Story
The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, is mentioned in this news brief. Read More
Share This Story
BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.
Share This Story
Research by Sandeep Burma, PhD, professor and vice chair (research), and Bipasha Mukherjee, PhD, associate professor, both with the Department of Neurosurgery, was featured in this article. Read More
Share This Story
Research by The University of Texas Health Science Center at San Antonio was mentioned in this news segment. Listen Now
Share This Story